Insider Transactions in Q2 2022 at Spectrum Pharmaceuticals Inc (SPPI)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2022
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,667
-1.02%
|
$0
$0.84 P/Share
|
|
Jun 22
2022
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,096
-0.93%
|
$0
$0.81 P/Share
|
|
Jun 21
2022
|
Nora Brennan Officer |
SELL
Open market or private sale
|
Direct |
3,569
-0.98%
|
$0
$0.78 P/Share
|
|
Jun 21
2022
|
Nora Brennan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
334,507
+47.9%
|
-
|
|
Jun 21
2022
|
Francois Lebel Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
405,040
+38.12%
|
-
|
|
Jun 21
2022
|
Thomas J Riga Director |
BUY
Grant, award, or other acquisition
|
Direct |
405,040
+25.03%
|
-
|
|
Jun 21
2022
|
Keith M Mc Gahan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
246,085
+33.39%
|
-
|
|
Jun 21
2022
|
William Ashton Director |
SELL
Open market or private sale
|
Direct |
4,283
-9.12%
|
$0
$0.78 P/Share
|
|
Jun 21
2022
|
Dolatrai Vyas |
SELL
Open market or private sale
|
Direct |
4,283
-4.96%
|
$0
$0.78 P/Share
|
|
Jun 21
2022
|
Seth H. Z. Fischer Director |
SELL
Open market or private sale
|
Direct |
5,711
-16.42%
|
$0
$0.78 P/Share
|
|
Apr 05
2022
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,367
-0.54%
|
$1,367
$1.41 P/Share
|
|
Apr 04
2022
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,205
-0.47%
|
$1,205
$1.35 P/Share
|